<?xml version="1.0" encoding="UTF-8"?>
<p>Similarly, the challenges for large scale fabrication necessitate novelty from engineers and chemists, and regulatory policies have to facilitate access to trials and patients. Thus, employing these nanocarriers in clinical practice remains challenging and will represent a major focus in the next decades.</p>
